...
首页> 外文期刊>Internal medicine. >Low-Density Lipoprotein Apheresis Therapy for Steroid- and Cyclosporine-Resistant Idiopathic Membranous Nephropathy
【24h】

Low-Density Lipoprotein Apheresis Therapy for Steroid- and Cyclosporine-Resistant Idiopathic Membranous Nephropathy

机译:低密度脂蛋白植物植物植物和环孢菌素抗性特发性膜肾病疗法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We herein report three cases of Nephrotic Syndrome (NS) with idiopathic membranous nephropathy (IMN) in which the patients were resistant to steroid (PSL) and cyclosporine (CyA) therapy. All three patients had a high risk of renal failure because of persistently high levels of proteinuria. We performed low-density lipoprotein apheresis (LDL-A) and achieved complete remission in two cases. The third patients developed NS relapse and a deteriorating renal function; however, withdrawal from dialysis therapy was achieved. There are no proven therapies for treating patients with PSL- and CyA-resistant IMN with acute deteriorating renal function or difficulties in maintaining fluid balance. We evaluated the treatment course and physiological mechanisms and reviewed similar cases in the pertinent literature.
机译:我们在此报告了三种肾病综合征(NS)患者具有特发性膜肾病(IMN),其中患者对类固醇(PSL)和环孢菌素(CYA)治疗有抗性。 由于持续高水平的蛋白尿,所有这三名患者的肾功能衰竭风险很高。 我们进行了低密度脂蛋白血吸虫(LDL-A)并在两种情况下实现了完全缓解。 第三名患者开发了NS复发和肾功能恶化; 但是,实现了透析治疗的撤离。 没有经过验证的疗法治疗PSL-和CyAs抗性IMN患者,肾功能恶化肾功能或难以保持液体平衡。 我们评估了治疗课程和生理机制,并在相关文献中审查了类似病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号